Literature DB >> 24622013

Auditory and vestibular phenotypes associated with GATA3 mutation.

Wade Wei-De Chien1, Jennifer W Leiding, Amy P Hsu, Christopher Zalewski, Kelly King, Steven M Holland, Carmen Brewer.   

Abstract

OBJECTIVE: To report the auditory and vestibular phenotypes of patients with GATA3 mutation. STUDY
DESIGN: Case series of 6 patients.
SETTING: Tertiary referral center. PATIENTS: All patients had the classic triad of GATA3 deficiency: hypoparathyroidism, hearing loss, and renal dysplasia. Patients (29-60 yr old; mean age, 42.5 yr; 3 male and 3 female subjects) were confirmed to have heterozygous mutations involving GATA3 by Sanger sequencing.
INTERVENTIONS: Behavioral audiometry, distortion product otoacoustic emissions (DPOAEs), and auditory brainstem responses (ABRs) were used to assess hearing. Rotational vestibular testing was used to assess vestibular function.
RESULTS: All patients with GATA3 mutation presented with hearing loss during childhood. The mean 3-frequency (0.5/1/2 kHz) pure tone average was 67 dB HL (range, 50-83 dB HL; SD, 9.3). The average speech discrimination score was 73% (range, 36%-100%; SD, 15.9). DPOAEs were absent in all patients. ABRs were remarkably robust and provided no evidence of retrocochlear dysfunction. Some patients complained of dizziness, but rotary chair testing was normal across participants for whom testing occurred.
CONCLUSION: Patients with GATA3 mutation present with early-onset sensorineural hearing loss (SNHL). DPOAEs were absent, supporting outer hair cell dysfunction, whereas ABRs were present and robust. Rotational vestibular testing revealed no evidence of abnormal horizontal semicircular canal function.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24622013      PMCID: PMC4108448          DOI: 10.1097/MAO.0000000000000238

Source DB:  PubMed          Journal:  Otol Neurotol        ISSN: 1531-7129            Impact factor:   2.311


  24 in total

1.  Transcription factor GATA-3 alters pathway selection of olivocochlear neurons and affects morphogenesis of the ear.

Authors:  A Karis; I Pata; J H van Doorninck; F Grosveld; C I de Zeeuw; D de Caprona; B Fritzsch
Journal:  J Comp Neurol       Date:  2001-01-22       Impact factor: 3.215

2.  Expression of the transcription factors GATA3 and Pax2 during development of the mammalian inner ear.

Authors:  Grace Lawoko-Kerali; Marcelo N Rivolta; Matthew Holley
Journal:  J Comp Neurol       Date:  2002-01-21       Impact factor: 3.215

3.  Brief report: autosomal dominant familial hypoparathyroidism, sensorineural deafness, and renal dysplasia.

Authors:  R W Bilous; G Murty; D B Parkinson; R V Thakker; M G Coulthard; J Burn; D Mathias; P Kendall-Taylor
Journal:  N Engl J Med       Date:  1992-10-08       Impact factor: 91.245

4.  Identification of a novel insertion mutation in GATA3 with HDR syndrome.

Authors:  Yukari Mino; Takashi Kuwahara; Toshifumi Mannami; Keisuke Shioji; Koh Ono; Naoharu Iwai
Journal:  Clin Exp Nephrol       Date:  2005-03       Impact factor: 2.801

5.  GATA3 haploinsufficiency causes a rapid deterioration of distortion product otoacoustic emissions (DPOAEs) in mice.

Authors:  M A J van Looij; H van der Burg; R S van der Giessen; M M de Ruiter; J van der Wees; J H van Doorninck; C I De Zeeuw; G A van Zanten
Journal:  Neurobiol Dis       Date:  2005-07-01       Impact factor: 5.996

6.  Functional analysis of a novel GATA3 mutation in a family with the hypoparathyroidism, deafness, and renal dysplasia syndrome.

Authors:  Alireza Zahirieh; M Andrew Nesbit; Asif Ali; Kairong Wang; Ning He; Maria Stangou; Gerasimos Bamichas; Kostas Sombolos; Rajesh V Thakker; York Pei
Journal:  J Clin Endocrinol Metab       Date:  2005-02-10       Impact factor: 5.958

7.  Chromosome 10p deletion in a patient with hypoparathyroidism, severe mental retardation, autism and basal ganglia calcifications.

Authors:  Annapia Verri; Paola Maraschio; Koen Devriendt; Carla Uggetti; Emanuela Spadoni; Edward Haeusler; Antonio Federico
Journal:  Ann Genet       Date:  2004 Jul-Sep

8.  Genetic epidemiological studies of early-onset deafness in the U.S. school-age population.

Authors:  M L Marazita; L M Ploughman; B Rawlings; E Remington; K S Arnos; W E Nance
Journal:  Am J Med Genet       Date:  1993-06-15

9.  Hearing loss following Gata3 haploinsufficiency is caused by cochlear disorder.

Authors:  Jacqueline van der Wees; Marjolein A J van Looij; M Martijn de Ruiter; Helineth Elias; Hans van der Burg; Su-San Liem; Dorota Kurek; J Doug Engel; Alar Karis; Bert G A van Zanten; Chris I de Zeeuw; Frank G Grosveld; J Hikke van Doorninck
Journal:  Neurobiol Dis       Date:  2004-06       Impact factor: 5.996

10.  A novel GATA3 nonsense mutation in a newly diagnosed adult patient of hypoparathyroidism, deafness, and renal dysplasia (HDR) syndrome.

Authors:  Kazutaka Nanba; Takeshi Usui; Michikazu Nakamura; Yuko Toyota; Keisho Hirota; Tamiko Tamanaha; Sachiko-Tsukamoto Kawashima; Kanako Nakao; Akiko Yuno; Tetsuya Tagami; Mitsuhide Naruse; Akira Shimatsu
Journal:  Endocr Pract       Date:  2013 Jan-Feb       Impact factor: 3.443

View more
  5 in total

Review 1.  Genetic Disorders of Parathyroid Development and Function.

Authors:  Rebecca J Gordon; Michael A Levine
Journal:  Endocrinol Metab Clin North Am       Date:  2018-10-12       Impact factor: 4.741

2.  Dynamic Expression of Sox2, Gata3, and Prox1 during Primary Auditory Neuron Development in the Mammalian Cochlea.

Authors:  Koji Nishimura; Teppei Noda; Alain Dabdoub
Journal:  PLoS One       Date:  2017-01-24       Impact factor: 3.240

3.  Normative data for ages 18-45 for ocular motor and vestibular testing using eye tracking.

Authors:  Aura Kullmann; Robin C Ashmore; Alexandr Braverman; Christian Mazur; Hillary Snapp; Erin Williams; Mikhaylo Szczupak; Sara Murphy; Kathryn Marshall; James Crawford; Carey D Balaban; Michael Hoffer; Alexander Kiderman
Journal:  Laryngoscope Investig Otolaryngol       Date:  2021-08-21

4.  HDR syndrome with a novel mutation in GATA3 mimicking a congenital X-linked stapes gusher: a case report.

Authors:  Aram Yang; Jinsup Kim; Chang-Seok Ki; Sung Hwa Hong; Sung Yoon Cho; Dong-Kyu Jin
Journal:  BMC Med Genet       Date:  2017-10-26       Impact factor: 2.103

5.  Novel heterozygous GATA3 and SLC34A3 variants in a 6-year-old boy with Barakat syndrome and hypercalciuria.

Authors:  Sha Yu; Wen-Xia Chen; Wei Lu; Chao Chen; Yihua Ni; Bo Duan; Bin Wang; Huijun Wang; Zheng-Min Xu
Journal:  Mol Genet Genomic Med       Date:  2020-03-10       Impact factor: 2.183

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.